| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |